ArticleTechnology in cancer research & treatment

Continuous Low-Dose Apatinib Combined With WBRT Significantly Reduces Peritumoral Edema and Enhances the Efficacy of Symptomatic Multiple Brain Metastases in NSCLC.

Yue Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.